If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Internalisation of Management

27 Apr 2023 07:00

RNS Number : 5535X
Ceiba Investments Limited
27 April 2023
 

 

 

CEIBA INVESTMENTS LIMITED

 

(TICKER: CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

 

Internalisation of Management

 

 

The Board of CEIBA Investments Limited ("CEIBA" or the "Company") is pleased to announce that Heads of Terms have been agreed with certain group companies of abrdn plc ("abrdn") for CEIBA to internalise the Company's investment management arrangements. 

 

Sebastiaan Berger, the lead fund manager of CEIBA and a current employee of abrdn, will move to CEIBA as Chief Executive Officer, together with the existing management team (collectively the "Management Team") to ensure continuity of service.

 

Concurrently, 4K Keys Limited ("4K Keys"), a company owned by the Management Team, that currently provides consulting services to abrdn in connection with the management of CEIBA, will be appointed to provide strategic consulting services in respect of the real estate assets of the Company's subsidiaries aimed at generating positive cash flow for such subsidiaries and cash distributions to CEIBA and its shareholders.

 

There will be no change to the Board of Directors of the Company as a result of the internalisation.

 

Following the completion of the internalisation process, CEIBA will become a self-managed alternative investment fund. Subject to contract, the internalisation is expected to become effective on 30 June 2023.

 

John Herring, Chairman of CEIBA, said "The Board has concluded that internalising the Company's investment management is in the best interests of shareholders as it will substantially reduce the operating costs of the Company. The retention of the current Management Team provides continuity of knowledge and experience alongside the non-executive Board. On behalf of the Board of CEIBA, I would like to thank the team at abrdn for their support over the last 5 years and look forward to the next stage in CEIBA's development."

 

Neil Slater, Global Head of Real Assets at abrdn commented, "abrdn has been involved with CEIBA as manager and shareholder since its London listing in 2018. We have a large and successful real estate team managing many mandates where our research and process can deliver greater value to clients. CEIBA invests in a specialist area of the market where our approach is less able to add value, so we believe it is in shareholders' best interest for CEIBA to focus on cost-savings and for the internalisation to occur. We fully support this and remain significant shareholders in the Company. We have had constructive discussions with the Board and Management Team of CEIBA to facilitate the internalisation and we wish them well."

 

Sebastiaan Berger, lead fund manager of CEIBA, stated, "While the geo-political backdrop for the Company over the last five years has been very challenging, the return of tourism to Cuba and the easing of U.S. sanctions means that the prospect of healthy future income streams (in particular once Cuba's economy and liquidity position improve) in combination with the substantial cost reduction that is being achieved by the internalisation of management is good news for the Company and its stakeholders. The Management Team of CEIBA is fully committed and aligned to work towards the Company's success."

 

Contacts:

Evan Bruce-Gardyne

abrdn plc

Tel : 0131 372 2200

 

James Maxwell/James Waterlow

Singer Capital Markets

Tel : 020 7496 3000

 

 

Important Information

This information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

--- ENDS -----

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAIFMMTMTTTBBJ
12
Date   Source Headline
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
3rd Jul 20234:41 pmRNSUpdate re Internalisation of Management
28th Jun 20236:16 pmRNSResult of AGM
28th Jun 20236:05 pmRNSNet Asset Value(s)
27th Apr 20234:03 pmRNSAnnual Financial Report - Replacement
27th Apr 20237:00 amRNSInternalisation of Management
27th Apr 20237:00 amRNSAnnual Financial Report
7th Feb 20231:07 pmRNSHolding(s) in Company
14th Dec 20221:14 pmRNSCorrection: Half-year Report
1st Dec 20227:00 amRNSService Providers and Registered Office
30th Nov 202212:22 pmRNSNet Asset Value(s)
28th Sep 20227:00 amRNSHalf-year Report
1st Aug 20224:53 pmRNSAlternative Investment Fund Manager–Change of Name
4th Jul 202210:02 amRNSNet Asset Value(s)
16th Jun 20225:34 pmRNSResult of AGM
25th May 20223:38 pmRNSCorrection: Annual Financial Report
29th Apr 20229:45 amRNSAnnual Financial Report
23rd Feb 20227:00 amRNSNet Asset Value(s)
22nd Feb 20227:00 amRNSTrading Update
19th Jan 20224:48 pmRNSHolding(s) in Company
31st Dec 20211:27 pmRNSHolding(s) in Company
31st Dec 20211:26 pmRNSHolding(s) in Company
26th Nov 20214:34 pmRNSHolding(s) in Company
26th Nov 20213:24 pmRNSHolding(s) in Company
1st Oct 20217:00 amRNSAppointment of Non-Executive Director
28th Sep 20217:00 amRNSHalf-year Report
17th Jun 20212:47 pmRNSResult of AGM
28th Apr 20217:00 amRNSAnnual Financial Report
14th Apr 20217:00 amRNSListing of Convertible Bonds
31st Mar 202112:16 pmRNSTrading Statement
15th Jan 20217:00 amRNSNet Asset Value(s)
16th Dec 20207:00 amRNSTrading Statement
3rd Dec 20204:30 pmRNSResult of Extraordinary Meeting
13th Nov 20207:00 amRNSNotice of EGM
23rd Oct 20207:00 amRNSTrading Statement
9th Oct 20204:59 pmRNSHalf-year Report
29th Sep 20207:00 amRNSHalf-year Report
19th Jun 20204:00 pmRNSResult of AGM
8th Jun 20207:00 amRNSTrading Statement
20th May 20205:40 pmRNSNet Asset Value(s)
28th Apr 20207:00 amRNSAnnual Financial Report
3rd Apr 20207:00 amRNSTrading Statement
3rd Dec 20193:37 pmRNSChange of Auditor
6th Nov 201912:32 pmRNSNet Asset Value(s)
30th Sep 20197:00 amRNSHalf-year Report
18th Jun 20195:27 pmRNSResult of AGM
13th Jun 20194:38 pmRNSHolding(s) in Company
11th Jun 201910:53 amRNSPublication of Supplementary Prospectus
3rd Jun 201912:59 pmRNSTrading Statement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.